Phase 1 trial of valemetostat and darolutamide in mCRPC

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522512-16-00

Enrollment

Registered

2026-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Castration Resistant Prostate Cancer (mCRPC)

None listed

Sex/Gender

Male

Age

18 Years to No maximum

None listed

Source: EU CTIS · Data processed: Mar 21, 2026